CEPO vs CRL · $271.1M cap vs rev $2.00B
Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO) is a shell companies company listed on NASDAQ.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
CEPO does not have a complete income-statement cache yet.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CEPO currently screens at market cap $271.1M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CEPO and CRL stock pages for the full models.
Not investment advice.